Recombinant Human Soluble Thrombomodulin Prevents Acute Lung Injury in a Rat Cardiopulmonary Bypass Model

被引:0
作者
Hirao, Shingo
Minakata, Kenji
Masumoto, Hidetoshi
Setozaki, Shuji
Yamazaki, Kazuhiro
Ikeda, Tadashi
Sakata, Ryuzo
机构
关键词
Cardiopulmonary bypass; Inflammation; Apoptosis;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
14828
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Recombinant Human Soluble Thrombomodulin Prevents Acute Lung Injury in a Rat Cardiopulmonary Bypass Model
    Hirao, Shingo
    Minakata, Kenji
    Masumoto, Hidetoshi
    Setozaki, Shuji
    Yamazaki, Kazuhiro
    Ikeda, Tadashi
    Sakata, Ryuzo
    CIRCULATION, 2016, 134
  • [2] Recombinant human soluble thrombomodulin prevents acute lung injury in a rat cardiopulmonary bypass model
    Hirao, Shingo
    Minakata, Kenji
    Masumoto, Hidetoshi
    Yamazaki, Kazuhiro
    Ikeda, Tadashi
    Minatoya, Kenji
    Sakata, Ryuzo
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2017, 154 (06) : 1973 - +
  • [3] Phosphodiesterase type 4 inhibitor prevents acute lung injury induced by cardiopulmonary bypass in a rat model
    Hamamoto, M
    Suga, M
    Nakatani, T
    Takahashi, Y
    Sato, Y
    Inamori, S
    Yagihara, T
    Kitamura, S
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2004, 25 (05) : 833 - 838
  • [4] Matrix metalloproteinase inhibitor prevents acute lung injury after cardiopulmonary bypass
    Carney, DE
    Lutz, CJ
    Picone, AL
    Gatto, LA
    Ramamurthy, NS
    Golub, LM
    Simon, SR
    Searles, B
    Paskanik, A
    Snyder, K
    Finck, C
    Schiller, HJ
    Nieman, GF
    CIRCULATION, 1999, 100 (04) : 400 - 406
  • [5] The N-terminal lectin-like domain of thrombomodulin reduces acute lung injury without anticoagulant effects in a rat cardiopulmonary bypass model
    Itonaga, Tatsuya
    Hirao, Shingo
    Yamazaki, Kazuhiro
    Ikeda, Tadashi
    Minatoya, Kenji
    Masumoto, Hidetoshi
    GENERAL THORACIC AND CARDIOVASCULAR SURGERY, 2020, 68 (08) : 785 - 792
  • [6] The N-terminal lectin-like domain of thrombomodulin reduces acute lung injury without anticoagulant effects in a rat cardiopulmonary bypass model
    Tatsuya Itonaga
    Shingo Hirao
    Kazuhiro Yamazaki
    Tadashi Ikeda
    Kenji Minatoya
    Hidetoshi Masumoto
    General Thoracic and Cardiovascular Surgery, 2020, 68 : 785 - 792
  • [7] Synergistic effects of recombinant human soluble thrombomodulin and fluid-volume resuscitation in a rat lethal crush injury model
    Mohri, Tomoyoshi
    Tanaka, Hiroshi
    Tajima, Goro
    Kajino, Kentaro
    Sonoi, Hideaki
    Hosotsubo, Hideo
    Ogura, Hiroshi
    Kuwagata, Yasuyuki
    Shimazu, Takeshi
    Sugimoto, Hisashi
    SHOCK, 2006, 26 (06): : 581 - 586
  • [8] Protective Effects of Recombinant Human Soluble Thrombomodulin on Lipopolysaccharide-Induced Acute Kidney Injury
    Nozaki, Yuji
    Ri, Jinhai
    Sakai, Kenji
    Niki, Kaoru
    Funauchi, Masanori
    Matsumura, Itaru
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (07)
  • [9] Recombinant human soluble thrombomodulin protects against brain injury in a CVST rat model, via downregulation of the HMGB1-RAGE axis
    Gu, Jian-Jun
    Chen, Jie-Bin
    Zhang, Jian-He
    Zhang, Hao
    Wang, Shou-Sen
    MOLECULAR MEDICINE REPORTS, 2016, 14 (06) : 5217 - 5222
  • [10] Combination effect of antithrombin and recombinant human soluble thrombomodulin in a lipopolysaccharide induced rat sepsis model
    Iba, Toshiaki
    Nakarai, Etsuro
    Takayama, Toshio
    Nakajima, Kenji
    Sasaoka, Tetsumasa
    Ohno, Yoichi
    CRITICAL CARE, 2009, 13 (06):